<!DOCTYPE html>
<html>
<head>
<title>MaxLinear, Inc. Quarterly report pursuant to Section 13 or 15(d)</title>
<link href="https://investors.maxlinear.com/stylesheets/ir.stockpr.css" rel="stylesheet" type="text/css">
<script type="text/javascript" src="https://investors.maxlinear.com/javascripts/ir.js"></script>
<link rel="stylesheet" type="text/css" href="https://ir.stockpr.com/stylesheets/xbrl.css">
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.min.js"></script>
<script type="text/javascript" src="https://ir.stockpr.com/javascripts/xbrl.js"></script>
</head>
<body>
<style>
body {
font-family: Arial, Helvetica, sans-serif;
font-size: 12px;
color: #454545;
}
</style>
<div class="xbrl-content">
    <h3>Quarterly report pursuant to Section 13 or 15(d)</h3>
    <div id="xbrl-menu-top">
        <div class="navigation">
            <ul class="xbrl-sf-menu">
                
                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3065">Cover</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3065">Cover</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3066">Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3066">Consolidated Balance Sheets</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3067">Consolidated Balance Sheets (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3068">Consolidated Statements of Operations</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3069">Consolidated Statements of Comprehensive Income (Loss)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3070">Consolidated Statements of Comprehensive Income (Loss) (Parenthetical)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3071">Consolidated Statement of Stockholders' Equity</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3072">Consolidated Statements of Cash Flows</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3073">Notes to Financial Statements</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3073">Organization and Summary of Significant Accounting Policies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3074">Net Income Per Share</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3075">Business Combinations</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3076">Restructuring Activity</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3077">Goodwill and Intangible Assets</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3078">Financial Instruments</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3079">Balance Sheet Details</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3080">Debt</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3081">Stock-Based Compensation</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3082">Income Taxes</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3083">Concentration of Credit Risk, Significant Customers and Geographic Information</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3084">Revenue from Contracts with Customers</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3085">Leases</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3086">Employee Retirement Plans</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3087">Commitments and Contingencies</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3088">Stock Repurchases</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3089">Subsequent Events</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3090">Pay vs Performance Disclosure</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3091">Insider Trading Arrangements</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3092">Accounting Policies</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3092">Organization and Summary of Significant Accounting Policies (Policies)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item " href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3093">Notes Tables</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3093">Net Income Per Share (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3094">Business Combinations (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3095">Restructuring Activity (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3096">Goodwill and Intangibles Assets (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3097">Financial Instruments (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3098">Balance Sheet Details (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3099">Debt (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3100">Stock-Based Compensation (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3101">Concentration of Credit Risk, Significant Customers and Geographic Information (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3102">Revenue from Contracts with Customers (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3103">Leases (Tables)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3104">Commitments and Contingencies (Tables)</a></li>
                                                    </ul>
                    </li>
                                    <li>
                        <a class="menu-item current" href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3105">Notes Details</a>
                        <ul class="submenu">
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3105">Net Income Per Share - Summary of Basic and Diluted Earnings Per Share (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3106">Net Income Per Share - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3107">Business Combinations - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3108">Business Combinations - Schedule of Business Acquisitions, by Acquisition (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3109">Restructuring Activity - Restructuring and Related Costs (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3110">Restructuring Activity - Schedule of Restructuring Reserve by Type of Cost (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3111">Goodwill and Intangible Assets - Summary of Goodwill (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3112">Goodwill and Intangibles Assets - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3113">Goodwill and Intangibles Assets - Schedule of Acquired Finite-Lived Intangible Assets by Major Class (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3114">Goodwill and Intangible Assets - Finite-lived Intangible Assets Amortization Expense (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3115">Goodwill and Intangibles Assets - Schedule of Finite-Lived Intangible Assets (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3116">Goodwill and Intangibles Assets - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3117">Financial Instruments - Composition of Financial Instruments (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3118">Financial Instruments - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3119">Financial Instruments - Fair Value, Assets and Liabilities Measured on Recurring Basis (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3120">Financial Instruments - Summary of Level 3 Financial Instrument Activity (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3121">Balance Sheet Details - Cash, Cash Equivalents and Restricted Cash (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3122">Balance Sheet Details - Inventory (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3123">Balance Sheet Details - Property and Equipment, Net (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3124">Balance Sheet Details - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3125">Balance Sheet Details - Accrued Price Protection Liability (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3126">Balance Sheet Details - Accrued Expenses and Other Current Liabilities (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3127">Balance Sheet Details - Schedule of Accumulated Other Comprehensive Income (Loss) by Component (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3128">Debt - Schedule of Debt (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3129">Debt - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3130">Stock-Based Compensation - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3131">Stock-Based Compensation - Stock-Based Compensation Expense (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3132">Stock-Based Compensation - Summary of Restricted Stock Unit and Performance-Based Restricted Stock Unit Activity (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3133">Stock-Based Compensation - Employee Stock Purchase Plan, Valuation Assumptions (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3134">Stock-Based Compensation - Summary of Stock Option Activity (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3135">Income Taxes (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3136">Concentration of Credit Risk, Significant Customers and Geographic Information - Concentration of Risk, by Risk Factor (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3137">Concentration of Credit Risk, Significant Customers and Geographic Information - Revenue from External Customers by Geographic Areas (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3138">Concentration of Credit Risk, Significant Customers and Geographic Information - Long-Lived Assets by Geographic Areas (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3139">Revenue from Contracts with Customers - Revenues from External Customers by Products and Services (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3140">Revenue from Contracts with Customers - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3141">Leases - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3142">Leases - Aggregate Future Minimum Payments Due (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3143">Employee Retirement Plans (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3144">Commitments and Contingencies - Future Minimum Inventory Purchase and Other Obligations (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3145">Commitments and Contingencies - Additional Information (Details)</a></li>
                                                            <li><a href="https://investors.maxlinear.com/all-sec-filings/xbrl_doc_only/3146">Stock Repurchases (Details)</a></li>
                                                    </ul>
                    </li>
                            </ul>
        </div>
    </div>
    <div class="spr-xbrl-document">
        <h4>Goodwill and Intangibles Assets - Additional Information (Details)</h4>
        11a
<?xml version="1.0" encoding="UTF-8"?>
<Error><Code>InternalError</Code><Message>We encountered an internal error. Please try again.</Message><RequestId>713GQ5CYP9TYMJZP</RequestId><HostId>L2hJ5G9v3MDDncVsRzk/jRFsJ0/lF9g7UHU2JFfdAcFDSQga9nheo8i40niAMva1iuxx41On4kQ=</HostId></Error>
0

        <div style="clear:both;"></div>
    </div>
</div>
</body>
</html>